share_log

Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19

Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19

傑富瑞維持對replimune集團的買入評級,將目標價格上調至19美元
Benzinga ·  12/04 15:53  · 評級/大行評級

Jefferies analyst Roger Song maintains Replimune Group (NASDAQ:REPL) with a Buy and raises the price target from $16 to $19.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論